Jeffrey Ubben's position in Bausch Health Companies is currently worth $99.7 Million. That's 1.68% of their equity portfolio (10th largest holding). The investor owns 3.97% of the outstanding Bausch Health Companies stock. The first Bausch Health Companies trade was made in Q3 2018. Since then Jeffrey Ubben bought shares four more times and sold shares on five occasions. The investor's estimated purchase price is $307 Million, resulting in a loss of 67%.